Corrigendum to “IDO1: An important immunotherapy target in cancer treatment” [Int. Immunopharmacol. 47 (2017) 70–77]Fangxuan Li,Rupeng Zhang,Shixia Li,Juntian LiuInternational Immunopharmacology(2017)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要